Modern Diagnostic & Research Centre Limited IPO Details

SME

Modern Diagnostic & Research Centre IPO DRHP (Draft Red Herring Prospectus) has been Exchange Approval Received.

Modern Diagnostic & Research Centre IPO total issue size comprises 41,00,000 shares . This includes a fresh issue of 41,00,000 shares .

The Lead Managers for Modern Diagnostic & Research Centre IPO are crucial for the offering's success. They are responsible for a wide range of tasks, including preparing the company for the public market, managing the regulatory filings, and marketing the IPO to potential investors. The lead manager for this offering is Beeline Capital Advisors Pvt Ltd. To assess their past performance and success in previous IPOs, you can view the Lead Manager Performance Summary report.

For detailed information, Refer to the Modern Diagnostic & Research Centre Limited DRHP.

Modern Diagnostic & Research Centre IPO Details

Open Date
-
Close Date
-
Listing Date
-
Issue Price
₹0 - ₹0
Face Value
₹10 per share
Lot Size
0
GMP
₹0
Issue Type
IPO
Listing On
BSE
Type
Book Built Issue
Share holding pre issue
11000000
Share holding post issue
-
Total Issue Size
41,00,000 shares
Fresh Issue
41,00,000 shares
Offer for Sale
-
DRHP Status
Exchange Approval Received

Modern Diagnostic & Research Centre IPO Lot Size

ApplicationLotsSharesAmount
To be announced

Modern Diagnostic & Research Centre IPO Reservation

Promoter Holding

Pre Issue:100.00%
Post Issue:-
Promoter Names:
Mr. Devendra Singh Yadav, Mrs. Deepali Yadav, Mrs. Asha Yadav, Mr. Jitendra Singh

Modern Diagnostic & Research Centre IPO Valuations

ROE:65.40%
ROCE:25.58%
DEBT/EQUITY:1.74
RONW:49.28%
PAT MARGIN:8.63

Modern Diagnostic & Research Centre Financial Information

Period Ended30 Sep 202431 Mar 202431 Mar 202331 Mar 2022
Assets57.7949.4936.5448.7
Revenue40.3368.6756.6160.58
Profit After Tax4.965.79-5.73-1.45
Net Worth16.7111.765.9611.7
Reserves and Surplus15.7110.764.9610.7
Total Borrowing21.1320.4615.3120.4
Amount in ₹ Crore

About Modern Diagnostic & Research Centre IPO

Incorporated in 1985, Modern Diagnostic & Research Centre Limited (MDRC) is a diagnostic chain in India, offering a comprehensive range of pathology and radiology services.

The company provides reliable diagnostic tests, home specimen collection, online reports, and customized test packages for institutional customers and patients based on their specific needs.

The company operates 21 centers (17 labs, 4 diagnostic centers) across 8 states, offering diagnostic services like ultrasound, CT, MRI, X-ray, ECG, PFT, and specialized labs for heart and neuro care.

Services:

  • Pathology:MDRC provides a wide array of tests, including high-end molecular diagnostics, cytogenetics, and specialized panels for genetic disorders and cancer.
  • Radiology:The centre offers advanced imaging services such as MRI, CT scans, ultrasound, and digital X-rays, utilizing state-of-the-art equipment like a 3-Tesla MRI machine and a 128-slice CT scanner.
  • Home Sample Collection:MDRC offers home blood sample collection services in several cities, providing convenience for patients unable to visit the centre.

As on February 28, 2025, the company has total 570 Employees including Consultants and doctors.

Strength Of Modern Diagnostic & Research Centre IPO

To be announced

Risk Of Modern Diagnostic & Research Centre IPO

To be announced

Objectives Modern Diagnostic & Research Centre IPO

1. Funding capital expenditure for purchase of medical Equipments for diagnostic centre and laboratories

2. Funding Working Capital Requirement

3. Repayment of certain outstanding borrowings availed by the Company

4. General Corporate Expenses

Company Contact Details

Modern Diagnostic & Research Centre Limited
Plot No H-64,1st Floor BLK-H,
Bali Nagar City landmark near Khetar Pal Hospital,
Ramesh Nagar, West Delhi, New Delhi
Phone: 9999474297
Email: compliance@mdrcindia.com
Website: http://www.mdrcindia.com/

Registrar Contact Details

Name: MUFG Intime India Private Limited
Phone: +91-22-4918 6270
Email:

Market Maker

To be announced

Comments